FY2027 EPS Estimates for Senseonics Lifted by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS) – Research analysts at HC Wainwright raised their FY2027 EPS estimates for shares of Senseonics in a note issued to investors on Monday, July 14th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of ($0.02) for the year, up from their prior forecast of ($0.03). HC Wainwright currently has a “Buy” rating and a $1.40 price objective on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($0.14) per share. HC Wainwright also issued estimates for Senseonics’ FY2029 earnings at $0.03 EPS.

SENS has been the subject of a number of other reports. Mizuho assumed coverage on Senseonics in a research report on Thursday, April 10th. They issued an “outperform” rating and a $2.00 price target for the company. Wall Street Zen upgraded Senseonics to a “sell” rating in a research note on Monday, May 12th. Finally, TD Cowen started coverage on Senseonics in a report on Tuesday. They issued a “buy” rating and a $1.25 price target for the company.

Senseonics Stock Performance

SENS opened at $0.56 on Wednesday. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The company has a market cap of $368.39 million, a price-to-earnings ratio of -4.33 and a beta of 0.92. Senseonics has a 1-year low of $0.25 and a 1-year high of $1.40. The company’s fifty day moving average price is $0.52 and its two-hundred day moving average price is $0.68.

Hedge Funds Weigh In On Senseonics

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. First Light Asset Management LLC purchased a new position in shares of Senseonics in the 4th quarter valued at approximately $3,366,000. Jane Street Group LLC lifted its position in Senseonics by 6,694.1% in the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after buying an additional 6,028,726 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Senseonics during the fourth quarter worth about $720,000. Informed Momentum Co LLC acquired a new stake in Senseonics in the first quarter valued at approximately $559,000. Finally, Millennium Management LLC increased its stake in Senseonics by 299.0% in the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company’s stock valued at $569,000 after purchasing an additional 815,332 shares during the last quarter. Institutional investors own 12.36% of the company’s stock.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.